These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33140522)

  • 1. Validation of a new hand function outcome measure in individuals with Charcot-Marie-Tooth disease.
    Prada V; Robbiano G; Mennella G; Hamedani M; Bellone E; Grandis M; Schenone A; Zuccarino R
    J Peripher Nerv Syst; 2020 Dec; 25(4):413-422. PubMed ID: 33140522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing overwork weakness in Charcot-Marie-tooth disease: Is it true or false?
    Prada V; Mori L; Accogli S; Rivarola M; Schizzi S; Hamedani M; Schenone A
    J Peripher Nerv Syst; 2018 Jun; 23(2):124-128. PubMed ID: 29693294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy.
    Alberti MA; Mori L; Francini L; Poggi I; Monti Bragadin M; Bellone E; Grandis M; Maggi G; Reni L; Sormani MP; Tacchino A; Padua L; Prada V; Bove M; Schenone A
    J Peripher Nerv Syst; 2015 Dec; 20(4):410-4. PubMed ID: 26456943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life and upper limb disability in Charcot-Marie-Tooth disease: A pilot study.
    Mori L; Schenone C; Cotellessa F; Ponzano M; Aiello A; Lagostina M; Massucco S; Marinelli L; Grandis M; Trompetto C; Schenone A
    Front Neurol; 2022; 13():964254. PubMed ID: 36277933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of muscle strength and manual dexterity in patients with Charcot-Marie-Tooth disease.
    Kobesova A; Nyvltova M; Kraus J; Kolar P; Sardina A; Mazanec R; Andel R
    J Hand Ther; 2016; 29(1):66-72; quiz 72. PubMed ID: 26847322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tripod pinch strength and thumb opposition are the major determinants of manual dexterity in Charcot-Marie-Tooth disease type 1A.
    Videler AJ; Beelen A; van Schaik IN; Verhamme C; van den Berg LH; de Visser M; Nollet F
    J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):828-33. PubMed ID: 20562406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Italian version of the Charcot-Marie-Tooth Health Index.
    Pisciotta C; Ciafaloni E; Zuccarino R; Calabrese D; Saveri P; Fenu S; Tramacere I; Genovese F; Dilek N; Johnson NE; Heatwole C; Herrmann DN; Pareyson D;
    J Peripher Nerv Syst; 2020 Sep; 25(3):292-296. PubMed ID: 32511835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The application of scales and characteristics of disability in the common genotypes of Charcot-Marie-Tooth disease].
    Liu X; Zhang RX; Liu L; Xie YZ; Lin ZQ; Zhao Q; Cao WQ; Zhu XY; Li XB
    Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(2):131-136. PubMed ID: 33455129
    [No Abstract]   [Full Text] [Related]  

  • 9. Dynamometry of intrinsic hand muscles in patients with Charcot-Marie-Tooth disease.
    Selles RW; van Ginneken BT; Schreuders TA; Janssen WG; Stam HJ
    Neurology; 2006 Dec; 67(11):2022-7. PubMed ID: 17159111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and validity of the Manual Ability Measure-36 in persons with Charcot-Marie-Tooth disease.
    Poole JL; Huffman M; Hunter A; Mares C; Siegel P
    J Hand Ther; 2015; 28(4):364-7; quiz 368. PubMed ID: 26318522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidimensional evaluation is necessary to assess hand function in patients with Charcot-Marie-Tooth disease type 1A.
    Reynaud V; Conforto I; Givron P; Clavelou P; Cornut-Chauvinc C; Taithe F; Pereira B; Coudeyre E
    Ann Phys Rehabil Med; 2021 Mar; 64(2):101362. PubMed ID: 32109594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hand function in Charcot Marie Tooth: test retest reliability of some measurements.
    Svensson E; Häger-Ross C
    Clin Rehabil; 2006 Oct; 20(10):896-908. PubMed ID: 17008341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypothesis of overwork weakness in Charcot-Marie-Tooth: a critical evaluation.
    van Pomeren M; Selles RW; van Ginneken BT; Schreuders TA; Janssen WG; Stam HJ
    J Rehabil Med; 2009 Jan; 41(1):32-4. PubMed ID: 19197566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Charcot-Marie-Tooth Functional Outcome Measure (CMT-FOM).
    Eichinger K; Burns J; Cornett K; Bacon C; Shepherd ML; Mountain J; Sowden J; Shy R; Shy ME; Herrmann DN
    Neurology; 2018 Oct; 91(15):e1381-e1384. PubMed ID: 30232254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of CMT1A using Rasch analysis based CMT neuropathy and examination scores.
    Fridman V; Sillau S; Acsadi G; Bacon C; Dooley K; Burns J; Day J; Feely S; Finkel RS; Grider T; Gutmann L; Herrmann DN; Kirk CA; Knause SA; Laurá M; Lewis RA; Li J; Lloyd TE; Moroni I; Muntoni F; Pagliano E; Pisciotta C; Piscosquito G; Ramchandren S; Saporta M; Sadjadi R; Shy RR; Siskind CE; Sumner CJ; Walk D; Wilcox J; Yum SW; Züchner S; Scherer SS; Pareyson D; Reilly MM; Shy ME;
    Neurology; 2020 Mar; 94(9):e884-e896. PubMed ID: 32047073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manual dexterity in hereditary motor and sensory neuropathy type 1a: severity of limitations and feasibility and reliability of two assessment instruments.
    Videler AJ; Beelen A; van Schaik IN; de Visser M; Nollet F
    J Rehabil Med; 2008 Feb; 40(2):132-6. PubMed ID: 18509578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease.
    Cornett KM; Menezes MP; Bray P; Halaki M; Shy RR; Yum SW; Estilow T; Moroni I; Foscan M; Pagliano E; Pareyson D; Laurá M; Bhandari T; Muntoni F; Reilly MM; Finkel RS; Sowden J; Eichinger KJ; Herrmann DN; Shy ME; Burns J;
    JAMA Neurol; 2016 Jun; 73(6):645-51. PubMed ID: 27043305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining hand dominance using dynamometric grip strength testing as evidence for overwork weakness in Charcot-Marie-Tooth disease: a systematic review and meta-analysis.
    Roberts-Clarke D; Fornusek C; Fiatarone Singh MA; Burns J; Hackett DA
    Int J Rehabil Res; 2016 Sep; 39(3):189-96. PubMed ID: 27177353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are novel outcome measures for Charcot-Marie-Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study.
    Pazzaglia C; Padua L; Pareyson D; Schenone A; Aiello A; Fabrizi GM; Cavallaro T; Santoro L; Manganelli F; Coraci D; Gemignani F; Vitetta F; Quattrone A; Mazzeo A; Russo M; Vita G;
    Neuromuscul Disord; 2019 Apr; 29(4):310-316. PubMed ID: 30926199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensory evaluation of the hands in patients with Charcot-Marie-Tooth disease using Semmes-Weinstein monofilaments.
    Schreuders TA; Selles RW; van Ginneken BT; Janssen WG; Stam HJ
    J Hand Ther; 2008; 21(1):28-34; quiz 35. PubMed ID: 18215749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.